Clinical Trial

A Study of a Dietary Supplement on Serum Biomarkers in Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a pilot clinical study designed to evaluate the effects of a dietary supplement on selected blood-based nutritional biomarkers in healthy children aged 4 to 15 years. Approximately 24 children will be screened and enrolled to account for potential dropouts, with a target of 20 participants completing the study. Eligible participants will attend a screening and baseline visit, followed by daily intake of the study supplement for 4 weeks. After the supplementation period, participants will return to the clinic for an end-of-study visit. Blood samples will be collected at baseline and after 4 weeks to measure nutritional biomarkers, including vitamin D, vitamin B12, folate, omega-3 fatty acids, and standard blood count parameters. Additional assessments include height, weight, body mass index (BMI), and a socioeconomic questionnaire. Throughout the study, participants or their caregivers will record daily supplement intake, any medications taken, and any adverse events in a study diary. The results of this pilot study will provide preliminary data on the effects of the dietary supplement on serum biomarkers in children.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-27.
Trial Details
NCT Number NCT07385144
Lead Sponsor SF Research Institute, Inc.
Collaborators: Smarty Pants Vitamins
Conditions Nutritional Status, Serum Biomarkers
Enrollment 30 participants
Start Date 2026-01-30
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-03-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-04